CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, A.
Right arrow Articles by Gamulin, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, A.
Right arrow Articles by Gamulin, Z.
Canadian Journal of Anesthesia 52:390-396 (2005)
© Canadian Anesthesiologists' Society, 2005

Regional Anesthesia and Pain

Duration of analgesia is similar when 15, 20, 25 and 30 mL of ropivacaine 0.5% are administered via a femoral catheter

[La durée de l’analgésie est similaire quand 15, 20, 25 et 30 mL de ropivacaïne à 0,5 % sont administrés par un cathéter fémoral]

Anne Weber, MD*, Roxane Fournier, MD*, Nicolas Riand, MD{dagger} and Zdravko Gamulin, MD*

* From the Division of Anesthesiology, and
{dagger} the Clinic of Orthopedic Surgery, University Hospitals, Geneva, Switzerland.

Address correspondence to: Dr. A. Weber, Division of Anesthesiology, University Hospitals, 1211 Geneva 14, Switzerland. Phone: ++41 22 382 74 03; Fax: ++41 22 382 75 11; E-mail: Anne.Weber{at}hcuge.ch

Purpose: This dose-response study was designed to determine the most appropriate dose of ropivacaine 0.5% injected via an indwelling femoral catheter for perioperative peripheral analgesia for total knee replacement (TKR).

Methods: 84 patients were allocated randomly to four groups and received, via a femoral catheter, either 15, 20, 25 or 30 mL of ropivacaine 0.5% in a double-blind fashion. An anterior sciatic block with 20 mL bupivacaine 0.5% was also performed. The evolution of sensory block of femoral, obturator and lateral femoral cutaneous nerves and motor block of femoral nerve were tested every five minutes during the first 30 min. The percentage of patients with complete sensory block of both femoral and obturator nerves determined success rate. General anesthesia was then induced. After surgery, patient-controlled analgesia (PCA) with ropivacaine 0.2% was available via the femoral catheter. The interval between the initial injection and the first PCA administration determined duration of action.

Results: The duration of action was not different between the four solutions tested i.e., 534 ± 379 min for 15 mL, 799 ± 364 min for 20 mL, 624 ± 342 min for 25 mL and 644 ± 266 min for 30 mL. The percentage of patients with complete sensory femoral and obturator blocks was, respectively, 60%, 95%, 85% and 70% for 15, 20, 25 and 30 mL (P = 0.008/15 mL vs 20 mL).

Conclusion: Although there is no difference in duration of analgesia, because of better sensory spread, 20 mL of ropivacaine 0.5% appears to be the most appropriate dose for peripheral analgesia after TKR.




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
H. Jutzi, S. Blumehthal, and A. Borgeat
Ropivacaine 0.5% administered via a femoral catheter: is the obturator nerve also blocked?
Can J Anesth, January 1, 2006; 53(1): 109 - 110.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Canadian Anesthesiologists' Society.